Intense Pulsed Light Therapy with Optimal Pulse Technology as an Adjunct Therapy for Moderate to Severe Blepharitis-Associated Keratoconjunctivitis.

Fang RuanYunxiao ZangRuti SellaHongshuang LuShang LiKe YangTao JinNatalie A AfshariZhi-Qiang Pan Ying Jie

Published in: Journal of ophthalmology (2019)

IPL is a safe and effective adjuvant treatment for BKC and possibly more effective in reducing eyelid margin inflammation and prevents recurrences than MGX alone. This trial is registered with ChiCTR-ONN-17013864.

Keyphrases

oxidative stress
early stage
blood pressure
clinical trial
early onset
high intensity
phase iii
mouse model
bone marrow
cell therapy